Study guide
18.1 Aseptic Technique & Compounding Environments
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
18.1 Aseptic Technique & Compounding Environments
Key Takeaways Explain This Topic AI
USP <797> requires an ISO 7 buffer area and ISO 8 ante-area for sterile compounding, with all critical exposures performed inside an ISO 5 primary engineering control (PEC).
The PEC for non-hazardous sterile compounding is typically a horizontal laminar airflow workbench (LAFW); hazardous sterile drugs require a Class II BSC or compounding aseptic containment isolator (CACI).
First air is unobstructed air exiting the HEPA filter directly to the sterile site; the 6-inch rule keeps critical sites within 6 inches of the DCA where first air contacts them.
Correct garbing order is shoe covers, then hair/beard covers, then face mask, then hand hygiene, then gown, then sterile gloves; sterile gloves are donned last using aseptic technique.
Beyond-use dating for low-risk sterile preparations is up to 48 hours at room temperature or 14 days refrigerated under the older USP <797> categories; revised USP <797> assigns BUDs by category and risk, but the governing principle is that sterility and stability together limit BUD.
Last updated: August 2026
Sterile compounding prepares preparations that bypass the body's natural barriers, so any microbial contamination can reach the bloodstream directly. USP <797> is the enforceable United States Pharmacopeia chapter that sets facility, engineering, procedural, and quality requirements for compounded sterile preparations (CSPs). The DHA Pharmacist blueprint expects you to know the cleanroom classification scheme, the engineering controls, the garbing sequence, and the quality assurance tests.
The Graded Cleanroom Environment
Sterile compounding does not happen in a single clean room — it happens in a cascade of increasingly cleaner airspaces. Airborne particles are removed by high-efficiency particulate air (HEPA) filters as air moves from the cleanest space outward.
- Space ISO Class Particle limit (≥0.5 µm per m³) Function
- Buffer area (low/medium-risk) ISO 7 ≤352,000 Houses the PEC; clean but not the cleanest zone
- Ante-area ISO 8 ≤3,520,000 Gowning, hand hygiene, staging
- PEC (primary engineering control) ISO 5 ≤3,520 Direct compounding zone inside the LAFW/BSC/CACI
For high-risk compounding, the buffer area must also meet ISO 7 and the ante-area ISO 8, with additional air-change-rate requirements (typically ≥30 air changes per hour in the buffer). Pressure differentials are continuously monitored: the buffer is positively pressurized relative to the ante-area, and the ante-area is positive relative to surrounding non-cleanroom space.
Primary Engineering Controls (PEC)
The PEC is the ISO 5 device where sterile manipulations actually occur. Three main types appear on the exam:
Laminar airflow workbench (LAFW) — horizontal HEPA-filtered airflow. Used for non-hazardous sterile compounding. Air sweeps from the filter toward the operator.
Biological safety cabinet (BSC) — vertical airflow with personnel and product protection. Used for hazardous sterile drugs. A Class II B2 BSC is 100% exhausted to the outside (no recirculation) and is preferred for cytotoxic preparations.
Compounding aseptic isolator (CAI) and compounding aseptic containment isolator (CACI) — closed, glove-locked isolators that physically separate operator from product; CACI is the containment version for hazardous drugs.
Exam trap: A horizontal LAFW must never be used for hazardous or cytotoxic drugs because the airflow pushes hazardous aerosols toward the operator's breathing zone. Hazardous sterile compounding requires vertical-flow containment (BSC or CACI) under USP <800> .
First Air, DCA, and the 6-Inch Rule
First air is air that has just passed through the HEPA filter and has not contacted any object before reaching the critical site. The direct compounding area (DCA) is the region inside the PEC where first air contacts sterile sites. The 6-inch rule states that critical sites (vial stoppers, needle hubs, syringe tips, open container openings) should be kept within about 6 inches of the HEPA-filtered air stream. The exam often tests this as: if a sterile site is more than 6 inches from the first-air source or is blocked by an object, it is no longer in first air and is at risk.
Garbing Order
Garbing is sequenced so that the dirtiest operations come first and the most sterile item (sterile gloves) is donned last:
- Shoe covers — remove street-shoe contamination at the threshold
- Hair and beard covers — contain shedding fibers
- Face mask — placed before hand hygiene so mask handling does not recontaminate clean hands
Hand hygiene — per WHO technique: water and soap followed by alcohol-based hand rub, or an alcohol-based surgical hand rub alone where permitted
Gown — donned with sterile-to-sterile contact only; cuffs secured
Sterile gloves — donned last using closed-assisted gloving; then hands are washed with sterile 70% IPA (isopropyl alcohol) and allowed to dry before compounding
Exam trap: Sterile gloves are donned last, not first. Placing gloves before the gown guarantees the cuffs become contaminated.
Quality Assurance Tests
USP <797> mandates periodic competency verification:
Media-fill challenge — the operator simulates the most complex compounding process using sterile growth medium (trypticase soy broth). The fill is then incubated; any turbidity indicates microbial growth and aseptic failure. Frequency depends on risk level (low-risk: every 12 months; medium-risk: every 6 months; high-risk: every 3 months).
Gloved fingertip sampling — after garbing and before beginning compounding, the operator presses each gloved fingertip onto sterile contact plates to detect hand-borne contamination.
Surface sampling — contact plates or swabs are taken from defined PEC and work-surface sites on a defined schedule to detect environmental contamination.
Beyond-Use Dating (BUD) for CSPs
The BUD is the date or time after which a CSP must not be used. Under the older USP <797> risk categories that the DHA exam often references:
- Risk level Room temp (≤30 °C) Refrigerated (2–8 °C) Frozen (≤−20 °C)
- Low-risk ≤48 hours ≤14 days ≤45 days
- Medium-risk ≤30 hours ≤9 days ≤45 days
- High-risk ≤24 hours ≤3 days ≤45 days
The revised USP <797> (effective November 2023) replaces the risk-level table with category-based BUDs (immediate-use, category 1 ≤12 h, category 2 with default maxima of 1–7 days refrigerated depending on factors, category 3 with stricter requirements allowing longer dating). The unifying principle to remember: BUD is limited by whichever is shorter — the preparation's chemical/physical stability or its microbiological sterility risk. When in doubt, choose the shortest defensible BUD.
Exam trap: BUD is not the same as expiration date. The expiration date is set by the manufacturer for a commercially available product; the BUD is assigned by the compounder based on stability data and USP criteria.